Rifampicin-resistance mutations in the rpoB gene in Bacillus Velezensis CC09 have pleiotropic effects

Frontiers in Microbiology

Volumn 8, Issue FEB, 2017, Pages

  Cai, Xun Chao ^a   Xi, Huan ^a   Liang, Li ^a   Liu, Jia Dong ^a   Liu, Chang Hong ^a   Xue, Ya Rong ^a   Yu, Xiang Yang ^b  

^a NANJING UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Bacillus velezensis; Iturin A; Mutation; Rifampicin resistance; RNA polymerase

Indexed keywords

ITURIN A; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

AMINO ACID SUBSTITUTION; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS; BACILLUS VELEZENSIS CC09; BACTERIUM MUTANT; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; FUNGAL SPORE GERMINATION; GENE; GENE EXPRESSION; GENE MAPPING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROTITER PLATE ASSAY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PLEIOTROPY; POINT MUTATION; REAL TIME POLYMERASE CHAIN REACTION; RPOB GENE; SPOROGENESIS; TRANSCRIPTION REGULATION; UPREGULATION; WILD TYPE;

EID: 85014517820     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00178     Document Type: Article

References (50)

1. Alifano, P., Palumbo, C., Pasanisi, D., and Talà, A. (2015). Rifampicin-resistance, rpoB polymorphism and RNA polymerase genetic engineering. J. Biotechnol. 202, 60-77. doi: 10.1016/j.jbiotec.2014.11.024.
2. Arnaud, M., Chastanet, A., and Débarbouillé, M. (2004). New vector for efficient allelic replacement in naturally nontransformable, low-gc-content, gram-positive bacteria. Appl. Environ. Microbiol. 70, 6887-6891.
3. Cai, X., Kang, X., Xi, H., Liu, C., and Xue, Y. (2016). Complete genome sequence of the endophytic biocontrol strain Bacillus velezensis CC09. Genome Announc. 4:e1048. doi: 10.1128/genomeA.01048-16.
4. Cai, X. C., Li, H., Xue, Y. R., and Liu, C. H. (2013). Study of endophytic Bacillus amyloliquefaciens CC09 and its antifungal CLPs. J. Appl. Biol. Biotechnol. 1, 1-5.
5. Campbell, D. S., and Holt, C. E. (2001). Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation. Neuron 32, 1013-1026. doi: 10.1016/S0896-6273(01)00551-7.
6. Carata, E., Peano, C., Tredici, S. M., Ferrari, F., Talà, A., Corti, G., et al. (2009). Phenotypes and gene expression profiles of Saccharopolyspora erythraea rifampicin-resistant (Rif) mutants affected in erythromycin production. Microb. Cell Fact. 8, 18-32. doi: 10.1186/1475-2859-8-18.
7. Chu, F., Kearns, D. B., Mcloon, A., Chai, Y., Kolter, R., and Losick, R. (2008). A novel regulatory protein governing biofilm formation in Bacillus subtilis. Mol. Microbiol. 68, 1117-1127. doi: 10.1111/j.1365-2958.2008.06201.x.
8. Clinical and Laboratory Standards Institute [CLSI] (2012). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that grow Aerobically; Approved Standard-Ninth Edition. Wayne, PA: CLSI Documents M07-A9.
9. Dunlap, C. A., Kim, S. J., Kwon, S. W., and Rooney, A. P. (2015). Bacillus velezensis is not a later heterotypic synonym of Bacillus amyloliquefaciens; Bacillus methylotrophicus, Bacillus amyloliquefaciens subsp plantarum and 'Bacillus oryzicola' are later heterotypic synonyms of Bacillus velezensis based on phylogenomics. Int. J. Syst. Evol. Microbiol. doi: 10.1099/ijsem.0.000858 [Epub ahead of print].
10. Ebright, R. H. (2000). RNA polymerase: structural similarities between bacterial RNA polymerase and eukaryotic RNA polymerase II. J. Mol. Biol. 304, 687-698. doi: 10.1006/jmbi.2000.4309.
11. Goldstein, B. P. (2014). Resistance to rifampicin: a review. J. Antibiot. 67, 625-630. doi: 10.1038/ja.2014.107.
12. Graba, M., Sauvage, S., Moulin, F. Y., Urrea, G., Sabater, S., and Sanchez-Pérez, J. M. (2013). Interaction between local hydrodynamics and algal community in epilithic biofilm. Water Res. 47, 2153-2163. doi: 10.1016/j.watres.2013.01.011.
13. Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids Symp. Ser. 41, 95-98.
14. Hallstoodley, L., Costerton, J. W., and Stoodley, P. (2004). Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2, 95-108. doi: 10.1038/nrmicro821.
15. Hu, H., Zhang, Q., and Ochi, K. (2002). Activation of antibiotic biosynthesis by specified mutations in the rpoB gene (encoding the RNA polymerase beta subunit) of Streptomyces lividans. J. Bacteriol. 184, 3984-3991. doi: 10.1128/JB.184.14.3984-3991.2002.
16. Ingham, C. J., and Furneaux, P. A. (2000). Mutations in the β subunit of the Bacillus subtilis RNA polymerase that confer both rifampicin resistance and hypersensitivity to NusG. Microbiology 146, 3041-3049. doi: 10.1099/00221287-146-12-3041.
17. Jha, S. S., Joshi, S. J., and Geetha, S. J. (2016). Lipopeptide production by Bacillus subtilis, R1 and its possible applications. Braz. J. Microbiol. 47, 955-964. doi: 10.1016/j.bjm.2016.07.006.
18. Jin, D. J., Cashel, M., Friedman, D. I., Nakamaru, Y., Walter, W. A., and Gross, C. A. (1988a). Effects of rifampicin resistant rpoB mutations on antitermination and interaction with NusA in Escherichia coli. J. Mol. Biol. 204, 247-261. doi: 10.1016/0022-2836(88)90573-6.
19. Jin, D. J., and Gross, C. A. (1988). Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J. Mol. Biol. 202, 45-58. doi: 10.1016/0022-2836(88)90517-7.
20. Jin, D. J., and Gross, C. A. (1991). RpoB, a rifampicin-resistant termination-proficient RNA polymerase, has an increased Km for purine nucleotides during transcription elongation. J. Biol. Chem. 266, 14478-14485.
21. Jin, D. J., Walter, W., and Gross, C. A. (1988b). Characterization of the termination pheno-types of rifampicin resistant rpoB mutants in Escherichia coli. J. Mol. Biol. 202, 245-263. doi: 10.1016/0022-2836(88)90455-X.
22. Kearns, D. B., and Losick, R. (2003). Swarming motility in undomesticated Bacillus subtilis. Mol. Microbiol. 49, 581-590. doi: 10.1046/j.1365-2958.2003.03584.x.
23. Koumoutsi, A., Chen, X. H., Vater, J., and Borris, R. (2007). DegU and YczE positively regulate the synthesis of bacillomycin D by Bacillus amyloliquefaciens strain FZB42. Appl. Environ. Microbiol. 73, 6953-6964. doi: 10.1128/AEM.00565-07.
24. Langfelder, P., and Horvath, S. (2008). WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9:559. doi: 10.1186/1471-2105-9-559.
25. López, D., and Kolter, R. (2010). Functional microdomains in bacterial membranes. Gene Dev. 24, 1893-1902. doi: 10.1101/gad.1945010.
26. Luary, C., Martíne, Z., and Viveka, V. (2014). Mechanisms of post-transcriptional gene regulation in bacterial biofilms. Front. Cell. Infect. Microbiol. 4:38. doi: 10.3389/fcimb.2014.00038.
27. Martínez, L. C., and Vadyvaloo, V. (2014). Mechanisms of post-transcriptional gene regulation in bacterial biofilms. Front. Cell. Infect. Microbiol. 4:38. doi: 10.3389/fcimb.2014.00038.
28. Maughan, H., Galeano, B., and Nicholson, W. L. (2004). Novel rpoB mutations conferring rifampin resistance on Bacillus subtilis: global effects on growth, competence, sporulation, and germination. J. Bacteriol. 186, 2481-2486. doi: 10.1128/JB.186.8.2481-2486.2004.
29. Moeller, R., Vlašic, I., Reitz, G., and Nicholson, W. L. (2012). Role of altered rpoB alleles in Bacillus subtilis sporulation and spore resistance to heat, hydrogen peroxide, formaldehyde, and glutaraldehyde. Arch. Microbiol. 194, 759-767. doi: 10.1007/s00203-012-0811-4.
30. Mokrousov, I., Otten, T., Vyshnevskiy, B., and Narvskaya, O. (2003). Allele-specific rpoB PCR assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears. Antimicrob. Agents Chemother. 47, 2231-2235. doi: 10.1128/AAC.47.7.2231-2235.2003.
31. Ohsawa, T., Tsukahara, K., and Ogura, M. (2009). Bacillus subtilis response regulator DegU is a direct activator of pgsB transcription involved in γ-poly-glutamic acid synthesis. Biosci. Biotech. Biochem. 73, 2096-2102. doi: 10.1271/bbb.90341.
32. O'Neill, A., Oliva, B., Storey, C., Hoyle, A., Fishwick, C., and Chopra, I. (2000). RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 44, 3163-3166. doi: 10.1128/AAC.44.11.3163-3166.2000.
33. Perkins, A. E., and Nicholson, W. L. (2008). Uncovering new metabolic capabilities of Bacillus subtilis using phenotype profiling of rifampin-resistant rpoB mutants. J. Bacteriol. 190, 807-814. doi: 10.1128/JB.00901-07.
34. Schaeffer, P., Millet, J., and Aubert, J. P. (1965). Catabolic repression of bacterial sporulation. Proc. Natl. Acad. Sci. U.S.A. 54, 704-711. doi: 10.1073/pnas.54.3.704.
35. Schmittgen, T. D., and Livak, K. J. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101-1108. doi: 10.1038/nprot.2008.73.
36. Scoffone, V., Dondi, D., Biino, G., Borghese, G., Pasini, D., Galizzi, A., et al. (2013). Knockout of pgds, and ggt, genes improves γ-PGA yield in B. subtilis. Biotechnol. Bioeng. 110, 2006-2012. doi: 10.1002/bit.24846.
37. Sleight, S. C., Bartley, B. A., Lieviant, J. A., and Sauro, H. M. (2010). In-fusion biobrick assembly and re-engineering. Nucl. Acids Res. 38, 2624-2636. doi: 10.1093/nar/gkq179.
38. Suthar, H., and Nerurkar, A. (2016). Characterization of biosurfactant produced by Bacillus licheniformis, tt42 having potential for enhanced oil recovery. Appl. Biochem. Biotechnol. 180, 248-260. doi: 10.1007/s12010-016-2096-6.
39. Tanaka, Y., Kasahara, K., Hirose, Y., Murakami, K., Kugimiya, R., and Ochi, K. (2013). Activation and products of the cryptic secondary metabolite biosynthetic gene clusters by rifampin resistance (rpoB) mutations in actinomycetes. J. Bacteriol. 195, 2959-2970. doi: 10.1128/JB.00147-13.
40. Verhamme, D. T., Kiley, T. B., and Stanley-Wall, N. R. (2007). DegU coordinates multicellular behaviour exhibited by Bacillus subtilis. Mol. Microbiol. 65, 554-568. doi: 10.1111/j.1365-2958.2007.05810.x.
41. Verhamme, D. T., Murray, E. J., and Stanley-Wall, N. R. (2009). DegU and Spo0A jointly control transcription of two loci required for complex colony development by Bacillus subtilis. J. Bacteriol. 191, 100-108. doi: 10.1128/JB.01236-08.
42. Wang, G., Hosaka, T., and Ochi, K. (2008). Dramatic activation of antibiotic production in Streptomyces coelicolor by cumulative drug resistance mutations. Appl. Environ. Microbiol. 74, 2834-2840. doi: 10.1128/AEM.02800-07.
43. Wang, L. T., Lee, F. L., Tai, C. J., and Kuo, H. P. (2008). Bacillus velezensis is a later heterotypic synonym of Bacillus amyloliquefaciens. Int. J. Syst. Evol. Microbiol. 58, 671-675. doi: 10.1099/ijs.0.65191-0.
44. Wang, P., Guo, Q., Ma, Y., Li, S., Lu, X., Zhang, X., et al. (2015). DegQ regulates the production of fengycins and biofilm formation of the biocontrol agent Bacillus subtilis, NCD-2. Microbiol. Res. 178, 42-50.
45. Wang, R., Zhou, G., Liu, J., Li, D., and Meng, Q. (2014). Colonization of Bacillus subtilis Y13 in Camellia oleifera leaves and its effect on native bacteria. Biotechnol. Bull. 27, 162-167.
46. Wichelhaus, T. A., Schäfer, V., Brade, V., and Böddinghaus, B. (1999). Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 43, 2813-2816.
47. Xu, M., Zhou, Y. N., Goldstein, B. P., and Jin, D. J. (2005). Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibiotics. J. Bacteriol. 187, 2783-2792. doi: 10.1128/JB.187.8.2783-2792.2005.
48. Yang, H. F., Xue, Y. R., Yu, X. Y., and Liu, C. H. (2014). Optimization of iturin A synthesis in biocontrol Bacillus amyloliquefaciens CC09 using response surface technique. Chin. J. Biol. Control 30, 481-488.
49. Zhou, Y. N., and Jin, D. J. (1997). RNA polymerase beta mutations have reduced sigma70 synthesis leading to a hyper-temperature-sensitive phenotype of a sigma70 mutant. J. Bacteriol. 179, 4292-4298. doi: 10.1128/jb.179.13.4292-4298.1997.
50. Zhou, Y. N., and Jin, D. J. (1998). The rpoB mutants destabilizing initiation complexes at stringently controlled promoters behave like "stringent" RNA polymerases in Escherichia coli. Proc. Nat. Acad. Sci. U.S.A. 95, 2908-2913. doi: 10.1073/pnas.95.6.2908.